Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Arnold L. Oronsky currently holds 1,675,656 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arnold L. Oronsky has been a net buyer of TSRX stock. They have purchased $33.5M and sold $8.6M worth of shares.
Arnold L. Oronsky's most recent insider trade was on Sep 29, 2020, when they sold 1,620,101 shares at $0.00 per share.
Arnold L. Oronsky serves as Executive at Trius Therapeutics Inc (TSRX). They have executed 79 insider transactions totaling $42.1M over their tenure at the company.
Arnold L. Oronsky holds the position of Executive at Trius Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Arnold L. Oronsky has shown a buying trading pattern, with $33.5M in total purchases and $8.6M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Arnold L. Oronsky was on Feb 18, 2014, when they sold $7.3M worth of MGNX shares. This transaction involved 200,000 shares at $36.50 per share.
Arnold L. Oronsky currently owns 1,675,656 shares of Trius Therapeutics Inc (TSRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Arnold L. Oronsky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Arnold L. Oronsky has 79 Form 4 filings on record as an insider at Trius Therapeutics Inc.
Set alerts for Arnold L. Oronsky and 40,000+ other insiders.